Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program

被引:0
|
作者
Lattard, Claire [1 ]
Herledan, Chloe [1 ,2 ]
Reverdy, Thibaut [3 ]
Antherieu, Gabriel [4 ]
Caffin, Anne-Gaelle [1 ]
Cerfon, Marie-Anne [1 ]
Maire, Magali [1 ]
Rivat, Marine [1 ]
France, Stephanie [1 ]
Ghesquieres, Herve [4 ]
You, Benoit [2 ,3 ]
Freyer, Gilles [2 ,3 ]
Ranchon, Florence [1 ,2 ]
Rioufol, Catherine [1 ,2 ]
机构
[1] Clin Oncol, Hosp Civils Lyon, Unite Pharm, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
[2] Univ Lyon 1, CICLY, EA 3738, F-69921 Lyon, Oullins, France
[3] Hosp Civils Lyon, Unite Pharm Clin oncol, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
[4] Unite Hematol, Hosp Civils Lyon, Groupement Hospitalier Sud, F-69495 Pierre Benite, France
来源
ONCOLOGIST | 2024年 / 30卷 / 02期
关键词
oral anticancer agents; dose intensity; adherence; drug-drug interaction; patient-reported outcomes; RENAL-CELL CARCINOMA; CLINICAL PHARMACISTS; DRUG-INTERACTIONS; MEDICATION SAFETY; DOSE INTENSITY; CANCER; IMPACT; CARE; ADHERENCE; ONCOLOGY;
D O I
10.1093/oncolo/oyae241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Healthcare professionals are faced with the new challenges of preventing and managing drug-related problems (DRPs) with oral anticancer therapy (OAT): side-effects, drug-drug interactions (DDIs), non-adherence, or medication errors. This study aims to assess the impact of ONCORAL, a real-life multidisciplinary care plan for cancer patients based on community and hospital follow-up, for the first OAT cycle.Methods A prospective cohort study was conducted between October 1, 2021 and October 1, 2022 including all outpatients starting OAT treatment. During the first OAT cycle, the program consists of 6 weekly scheduled face-to-face or phone consultations to prevent and manage DRPs. Nurse and pharmacist interventions (NPIs) are realized to optimize treatments (primary outcomes). Secondary outcomes included the relative dose intensity (RDI) of the first cycle.Results A total of 562 NPIs were performed by the ONCORAL team: that is, 87.1% of the 209 patients included, for a mean of 3.1 +/- 2.2 NPIs/patient. NPIs-concerned DRPs detected by the nurse and pharmacist (346, 61.6%), symptoms and/or adverse effects reported as PROs by the patient or family (138, 24.6%), or pathway issues (78, 13.9%). Seventy-three DDIs were detected and managed during medication review, in a quarter of patients (n = 54/209), leading to the discontinuation of a daily concomitant medication in 30 cases. The mean RDI at the end of the first cycle, calculated for 209 patients, was 83.1 +/- 23.9% (17.56-144.23).Conclusion In these ambulatory cancer patients, the interest in tailored monitoring of DRPs as a whole, including the prevention and management of drug interactions in addition to symptoms and adverse effects, is highlighted. Healthcare professionals are faced with the new challenges of preventing and managing drug-related problems with oral anticancer therapy. This study assessed ONCORAL, a real-life multidisciplinary care plan.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study
    Huot, Laure
    Guerre, Pascale
    Descotes, Guillaume
    Caffin, Anne-Gaelle
    Herledan, Chloe
    Ranchon, Florence
    Rioufol, Catherine
    BMJ OPEN, 2023, 13 (03):
  • [22] Baby or Bathwater? Early Follow-up After Hospital Discharge
    Curtis, Jeptha P.
    CIRCULATION, 2013, 128 (11) : 1177 - 1178
  • [23] Follow-up of newborns and their mothers after early hospital discharge
    Egerter, SA
    Braveman, PA
    Marchi, KS
    CLINICS IN PERINATOLOGY, 1998, 25 (02) : 471 - +
  • [24] PHARMACODYNAMICS OF INTRAVENOUS LABETALOL AND FOLLOW-UP THERAPY WITH ORAL LABETALOL
    VLACHAKIS, ND
    MARONDE, RF
    MALOY, JW
    MEDAKOVIC, M
    KASSEM, N
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) : 503 - 508
  • [25] LUMPECTOMY AND RADIATION-THERAPY FOR EARLY BREAST-CARCINOMA - A COMMUNITY-HOSPITAL EXPERIENCE
    HALL, SW
    FELTNER, WR
    MIERCORT, RD
    HUME, RH
    MACKINTOSH, FR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 199 - 199
  • [26] A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients
    Sebat, F
    Johnson, D
    Musthafa, AA
    Watnik, M
    Moore, S
    Henry, K
    Saari, M
    CHEST, 2005, 127 (05) : 1729 - 1743
  • [27] Implementing a Structured Oral Examination into a Residency Program: A Follow-up Report
    Wiggins, Michael N.
    Harper, Richard A.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2009, 40 (05) : 524 - 524
  • [28] Impact of a geriatric pharmacist conducted hospital discharge follow-up program
    Poon, L. H.
    Nigro, S.
    Wittkop, E.
    Lee, A. J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S78 - S78
  • [29] HIGH-RISK FOLLOW-UP PROGRAM OF THE INFANT AND FAMILY IN THE COMMUNITY
    CLEMMENS, D
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1982, 73 (03): : 163 - 166
  • [30] COMMUNITY HYPERTENSION-CONTROL PROGRAM - FOLLOW-UP AND PATIENT COMPLIANCE
    MACHANN, WJ
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1976, 52 (06) : 665 - 670